VERACYTE INC (VCYT) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:VCYT • US92337F1075

36.19 USD
+1.33 (+3.82%)
At close: Feb 6, 2026
36.36 USD
+0.17 (+0.47%)
After Hours: 2/6/2026, 8:10:18 PM
Fundamental Rating

6

Taking everything into account, VCYT scores 6 out of 10 in our fundamental rating. VCYT was compared to 525 industry peers in the Biotechnology industry. While VCYT has a great health rating, its profitability is only average at the moment. VCYT is not overvalued while it is showing excellent growth. This is an interesting combination. These ratings would make VCYT suitable for growth investing!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • In the past year VCYT was profitable.
  • In the past year VCYT had a positive cash flow from operations.
  • In the past 5 years VCYT reported 4 times negative net income.
  • The reported operating cash flow has been mixed in the past 5 years: VCYT reported negative operating cash flow in multiple years.
VCYT Yearly Net Income VS EBIT VS OCF VS FCFVCYT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M

1.2 Ratios

  • The Return On Assets of VCYT (2.22%) is better than 89.31% of its industry peers.
  • VCYT has a better Return On Equity (2.41%) than 90.27% of its industry peers.
  • VCYT has a better Return On Invested Capital (2.93%) than 90.08% of its industry peers.
Industry RankSector Rank
ROA 2.22%
ROE 2.41%
ROIC 2.93%
ROA(3y)-2.66%
ROA(5y)-4.4%
ROE(3y)-2.83%
ROE(5y)-4.73%
ROIC(3y)N/A
ROIC(5y)N/A
VCYT Yearly ROA, ROE, ROICVCYT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

  • With an excellent Profit Margin value of 6.12%, VCYT belongs to the best of the industry, outperforming 90.08% of the companies in the same industry.
  • VCYT's Operating Margin of 9.70% is amongst the best of the industry. VCYT outperforms 91.60% of its industry peers.
  • Looking at the Gross Margin, with a value of 68.53%, VCYT belongs to the top of the industry, outperforming 81.11% of the companies in the same industry.
  • VCYT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 9.7%
PM (TTM) 6.12%
GM 68.53%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.39%
GM growth 5Y-0.79%
VCYT Yearly Profit, Operating, Gross MarginsVCYT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

8

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), VCYT is destroying value.
  • The number of shares outstanding for VCYT has been increased compared to 1 year ago.
  • Compared to 5 years ago, VCYT has more shares outstanding
  • VCYT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
VCYT Yearly Shares OutstandingVCYT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
VCYT Yearly Total Debt VS Total AssetsVCYT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

  • VCYT has an Altman-Z score of 15.97. This indicates that VCYT is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 15.97, VCYT belongs to the top of the industry, outperforming 87.40% of the companies in the same industry.
  • There is no outstanding debt for VCYT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 15.97
ROIC/WACC0.33
WACC8.86%
VCYT Yearly LT Debt VS Equity VS FCFVCYT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

  • A Current Ratio of 6.23 indicates that VCYT has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 6.23, VCYT is in the better half of the industry, outperforming 63.74% of the companies in the same industry.
  • VCYT has a Quick Ratio of 5.94. This indicates that VCYT is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of VCYT (5.94) is better than 63.17% of its industry peers.
Industry RankSector Rank
Current Ratio 6.23
Quick Ratio 5.94
VCYT Yearly Current Assets VS Current LiabilitesVCYT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

7

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 353.33% over the past year.
  • The Revenue has grown by 16.41% in the past year. This is quite good.
  • Measured over the past years, VCYT shows a very strong growth in Revenue. The Revenue has been growing by 29.93% on average per year.
EPS 1Y (TTM)353.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%26.32%
Revenue 1Y (TTM)16.41%
Revenue growth 3Y26.64%
Revenue growth 5Y29.93%
Sales Q2Q%13.82%

3.2 Future

  • Based on estimates for the next years, VCYT will show a very strong growth in Earnings Per Share. The EPS will grow by 51.21% on average per year.
  • The Revenue is expected to grow by 11.52% on average over the next years. This is quite good.
EPS Next Y78.93%
EPS Next 2Y94.08%
EPS Next 3Y63.11%
EPS Next 5Y51.21%
Revenue Next Year15.05%
Revenue Next 2Y13.16%
Revenue Next 3Y12.77%
Revenue Next 5Y11.52%

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
VCYT Yearly Revenue VS EstimatesVCYT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M 800M
VCYT Yearly EPS VS EstimatesVCYT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 1 -1 2

6

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 95.24, VCYT can be considered very expensive at the moment.
  • Based on the Price/Earnings ratio, VCYT is valued cheaply inside the industry as 89.69% of the companies are valued more expensively.
  • VCYT's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.92.
  • The Price/Forward Earnings ratio is 32.03, which means the current valuation is very expensive for VCYT.
  • VCYT's Price/Forward Earnings ratio is rather cheap when compared to the industry. VCYT is cheaper than 91.60% of the companies in the same industry.
  • VCYT's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.78.
Industry RankSector Rank
PE 95.24
Fwd PE 32.03
VCYT Price Earnings VS Forward Price EarningsVCYT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • 92.37% of the companies in the same industry are more expensive than VCYT, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, VCYT is valued cheaply inside the industry as 94.08% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 29.2
EV/EBITDA 34.84
VCYT Per share dataVCYT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • VCYT has a very decent profitability rating, which may justify a higher PE ratio.
  • VCYT's earnings are expected to grow with 63.11% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.21
PEG (5Y)N/A
EPS Next 2Y94.08%
EPS Next 3Y63.11%

0

5. Dividend

5.1 Amount

  • No dividends for VCYT!.
Industry RankSector Rank
Dividend Yield 0%

VERACYTE INC

NASDAQ:VCYT (2/6/2026, 8:10:18 PM)

After market: 36.36 +0.17 (+0.47%)

36.19

+1.33 (+3.82%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-04
Earnings (Next)02-25
Inst Owners114.83%
Inst Owner Change-2.01%
Ins Owners0.42%
Ins Owner Change-3.94%
Market Cap2.86B
Revenue(TTM)495.14M
Net Income(TTM)30.31M
Analysts82.11
Price Target49.7 (37.33%)
Short Float %6.58%
Short Ratio6.26
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-15.65%
Min EPS beat(2)-110.32%
Max EPS beat(2)79.03%
EPS beat(4)2
Avg EPS beat(4)-1.91%
Min EPS beat(4)-110.32%
Max EPS beat(4)79.03%
EPS beat(8)5
Avg EPS beat(8)108.97%
EPS beat(12)8
Avg EPS beat(12)67.3%
EPS beat(16)12
Avg EPS beat(16)58.01%
Revenue beat(2)2
Avg Revenue beat(2)4.54%
Min Revenue beat(2)3.31%
Max Revenue beat(2)5.76%
Revenue beat(4)3
Avg Revenue beat(4)2.42%
Min Revenue beat(4)-0.39%
Max Revenue beat(4)5.76%
Revenue beat(8)7
Avg Revenue beat(8)4.03%
Revenue beat(12)11
Avg Revenue beat(12)4.6%
Revenue beat(16)15
Avg Revenue beat(16)5.32%
PT rev (1m)0.75%
PT rev (3m)15.74%
EPS NQ rev (1m)3.75%
EPS NQ rev (3m)12.59%
EPS NY rev (1m)1.2%
EPS NY rev (3m)34.36%
Revenue NQ rev (1m)0.98%
Revenue NQ rev (3m)1.09%
Revenue NY rev (1m)0.48%
Revenue NY rev (3m)1.92%
Valuation
Industry RankSector Rank
PE 95.24
Fwd PE 32.03
P/S 5.78
P/FCF 29.2
P/OCF 26.56
P/B 2.27
P/tB 7.19
EV/EBITDA 34.84
EPS(TTM)0.38
EY1.05%
EPS(NY)1.13
Fwd EY3.12%
FCF(TTM)1.24
FCFY3.42%
OCF(TTM)1.36
OCFY3.77%
SpS6.26
BVpS15.91
TBVpS5.04
PEG (NY)1.21
PEG (5Y)N/A
Graham Number11.66
Profitability
Industry RankSector Rank
ROA 2.22%
ROE 2.41%
ROCE 3.71%
ROIC 2.93%
ROICexc 4.08%
ROICexgc 54.52%
OM 9.7%
PM (TTM) 6.12%
GM 68.53%
FCFM 19.79%
ROA(3y)-2.66%
ROA(5y)-4.4%
ROE(3y)-2.83%
ROE(5y)-4.73%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.39%
GM growth 5Y-0.79%
F-Score8
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 44.07%
Cap/Sales 1.97%
Interest Coverage 250
Cash Conversion 153.6%
Profit Quality 323.21%
Current Ratio 6.23
Quick Ratio 5.94
Altman-Z 15.97
F-Score8
WACC8.86%
ROIC/WACC0.33
Cap/Depr(3y)39.24%
Cap/Depr(5y)36.19%
Cap/Sales(3y)2.72%
Cap/Sales(5y)2.61%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)353.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%26.32%
EPS Next Y78.93%
EPS Next 2Y94.08%
EPS Next 3Y63.11%
EPS Next 5Y51.21%
Revenue 1Y (TTM)16.41%
Revenue growth 3Y26.64%
Revenue growth 5Y29.93%
Sales Q2Q%13.82%
Revenue Next Year15.05%
Revenue Next 2Y13.16%
Revenue Next 3Y12.77%
Revenue Next 5Y11.52%
EBIT growth 1Y427.6%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year320.9%
EBIT Next 3Y74.34%
EBIT Next 5Y48.27%
FCF growth 1Y236.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y180.39%
OCF growth 3YN/A
OCF growth 5YN/A

VERACYTE INC / VCYT FAQ

What is the fundamental rating for VCYT stock?

ChartMill assigns a fundamental rating of 6 / 10 to VCYT.


What is the valuation status of VERACYTE INC (VCYT) stock?

ChartMill assigns a valuation rating of 6 / 10 to VERACYTE INC (VCYT). This can be considered as Fairly Valued.


How profitable is VERACYTE INC (VCYT) stock?

VERACYTE INC (VCYT) has a profitability rating of 6 / 10.


Can you provide the PE and PB ratios for VCYT stock?

The Price/Earnings (PE) ratio for VERACYTE INC (VCYT) is 95.24 and the Price/Book (PB) ratio is 2.27.


What is the financial health of VERACYTE INC (VCYT) stock?

The financial health rating of VERACYTE INC (VCYT) is 8 / 10.